Increased tumour ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer
Ascorbate is a co-factor for the hydroxylases that regulate the transcription factor hypoxia-inducible factor (HIF)-1, which provides cancer cells with a metabolic and survival advantage in the hypoxic environment of solid tumors. However, whether ascorbate affects tumor development is a highly deba...
Main Authors: | Caroline eKuiper, Gabi eDachs, Delwyn eMunn, Margaret eCurrie, Bridget eRobinson, John Frederick Pearson, Margreet C M Vissers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00010/full |
Similar Items
-
Ascorbate as a cofactor for Fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumour growth and progression
by: Caroline eKuiper, et al.
Published: (2014-12-01) -
Gene and Protein Expression Is Altered by Ascorbate Availability in Murine Macrophages Cultured under Tumour-Like Conditions
by: Abel D. Ang, et al.
Published: (2021-03-01) -
Current limitations of murine models in oncology for ascorbate research
by: Elizabeth J Campbell, et al.
Published: (2014-10-01) -
Oxygen sensing; a stunningly elegant molecular machinery highjacked in cancer
by: Lena Claesson-Welsh
Published: (2020-07-01) -
A crosstalk between phosphorylation and ubiquitination of BNIP3 regulates mitophagy under hypoxia
by: Yun-Ling He, et al.
Published: (2023-12-01)